MKI67 and breast carcinoma: Mainly expressed in ER− breast cancer, including TNBC and especially in ductal TNBC, a high Ki-67 expression level is considered as a poor prognostic with predictive potential as it is associated with poor outcomes while high mitotic activity in the tumor shows a very good clinical response to combination chemotherapy [198].